# Erik P. Pioro

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/erik-p-pioro/

## Facts

| Field | Value |
| --- | --- |
| Citations | 8,039 |
| Field | Amyotrophic Lateral Sclerosis Research |
| h-index | 40 |
| i10-index | 92 |
| Last Known Institution | University of British Columbia |
| OpenAlex ID | https://openalex.org/A5067234869 |
| ORCID iD | 0000-0002-0737-6065 |
| Works | 176 |

## Researcher papers

- [Control of microglial neurotoxicity by the fractalkine receptor](https://scholariq.org/papers/control-of-microglial-neurotoxicity-by-the-fractalkine-receptor/)
- [Genome-wide Analyses Identify KIF5A as a Novel ALS Gene](https://scholariq.org/papers/genome-wide-analyses-identify-kif5a-as-a-novel-als-gene/)
- [Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect](https://scholariq.org/papers/dextromethorphan-plus-ultra-low-dose-quinidine-reduces-pseudobulbar-affect/)
- [A clinical trial of creatine in ALS](https://scholariq.org/papers/a-clinical-trial-of-creatine-in-als/)
- [Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions](https://scholariq.org/papers/imaging-of-axonal-damage-in-multiple-sclerosis-spatial-distribution-of-magnetic/)
- [Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III](https://scholariq.org/papers/phase-ii-trial-of-coq10-for-als-finds-insufficient-evidence-to-justify-phase-iii/)
- [A randomized controlled trial of resistance exercise in individuals with ALS](https://scholariq.org/papers/a-randomized-controlled-trial-of-resistance-exercise-in-individuals-with-als/)
- [Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS](https://scholariq.org/papers/validation-of-serum-neurofilaments-as-prognostic-and-potential-pharmacodynamic/)
- [A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis](https://scholariq.org/papers/a-randomized-placebo-controlled-trial-of-topiramate-in-amyotrophic-lateral/)
- [Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis](https://scholariq.org/papers/time-to-diagnosis-and-factors-affecting-diagnostic-delay-in-amyotrophic-lateral/)
- [The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosis](https://scholariq.org/papers/the-effects-of-intervention-with-intravenous-edaravone-in-study-19-on/)

## Researcher topics

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Neurogenetic and Muscular Disorders Research](https://scholariq.org/topics/neurogenetic-and-muscular-disorders-research/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)

## Researcher university

- [University of British Columbia](https://scholariq.org/institutions/university-of-british-columbia/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.